NCT00859053View on ClinicalTrials.gov

Single-Dose Pharmacokinetics of BMS-790052 in Participants With Hepatic Impairment

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Hepatic Insufficiency
Interventions
DRUG

BMS-790052

Capsules, Oral, 30 mg, single dose, one day

Trial Locations (2)

32809

Orlando Clinical Research Center, Orlando

92801

Advanced Clinical Research Institute, Anaheim

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY